SIBO in NYC: An Integrative Approach to Small Intestinal Bacterial Overgrowth

Understanding SIBO: More Than Just Bloating

Small Intestinal Bacterial Overgrowth (SIBO) is a condition in which bacteria—normally confined to the large intestine—colonize the small intestine in abnormally high numbers. The result is a dysbiotic environment that ferments carbohydrates early in the digestive process, producing excessive gas, triggering inflammation, and impairing nutrient absorption. For many NYC patients, SIBO is the hidden driver of symptoms that have been written off as IBS, anxiety, or functional GI complaints.

At Regen Health Physicians NYC, we approach SIBO as a systemic condition with identifiable root causes—not a diagnosis to be managed indefinitely with antibiotics. Our integrative protocol addresses the full picture: bacterial overgrowth, motility dysfunction, immune dysregulation, and the dietary and lifestyle factors that perpetuate the cycle.

Common Symptoms of SIBO

SIBO produces a characteristic constellation of symptoms, though presentation varies:

• Bloating and abdominal distension, especially after eating
• Flatulence and belching
• Abdominal cramping and discomfort
• Diarrhea, constipation, or alternating bowel habits
• Nausea after meals
• Nutritional deficiencies (B12, iron, fat-soluble vitamins)
• Brain fog and fatigue
• Skin issues (rosacea, eczema) associated with gut-skin axis disruption

Diagnosis: Breath Testing and Functional Assessment

The standard diagnostic tool for SIBO is lactulose or glucose breath testing, which measures hydrogen and methane gas produced by bacteria in the small intestine. At RHPNY, we use a 3-hour lactulose breath test to capture both hydrogen-dominant SIBO and methane-dominant SIBO (called IMO).

Beyond breath testing, our chronic disease workup may include:

• Comprehensive stool analysis (GI-MAP) to assess microbiome, parasites, and digestive markers
• Organic acids testing to assess microbial metabolites
• Nutrient panel (B12, folate, iron, vitamin D)
• Zonulin and intestinal permeability markers
• Thyroid panel (hypothyroidism impairs motility and drives SIBO)
• Autoimmune markers (anti-vinculin/anti-CdtB antibodies associated with post-infectious SIBO)

Root Cause Analysis: Why SIBO Develops

Treating bacterial overgrowth without addressing its cause results in high recurrence rates. At RHPNY, we systematically evaluate:

Motility Disorders

The migrating motor complex (MMC) sweeps bacteria from the small intestine every 90 minutes during fasting. Impaired MMC function—caused by hypothyroidism, diabetes, or nerve damage—allows bacteria to accumulate. Identifying and treating motility dysfunction is essential for sustained resolution.

Post-Infectious SIBO

Acute gastroenteritis from pathogens like Campylobacter can trigger autoimmune damage to the intestinal nervous system. This post-infectious pattern is common, underdiagnosed, and requires targeted treatment beyond antibiotics.

Structural Issues

Low stomach acid, impaired bile flow, or anatomical changes from prior surgery can compromise the defensive mechanisms that prevent bacterial overgrowth.

The RHPNY Integrative Treatment Protocol

Phase 1: Eradication

We use herbal antimicrobials (berberine, allicin, oregano oil, neem) or pharmaceutical antibiotics (rifaximin, neomycin for IMO) based on breath test results and patient tolerance. Both approaches have evidence supporting efficacy.

Phase 2: Motility Support

Prokinetics—medications or supplements that stimulate gut motility—are introduced during and after eradication to prevent recurrence. Low-dose naltrexone (LDN) is valuable here, providing both prokinetic and anti-inflammatory effects.

Phase 3: Restoration

Rebuilding the gut lining and supporting a healthy microbiome requires:

• Intestinal permeability repair (zinc carnosine, L-glutamine, colostrum)
• Strategic probiotic reintroduction (not during active SIBO—timing matters)
• Dietary guidance: Low-FODMAP diet during treatment, then structured reintroduction

Peptide Adjuncts

Peptides like BPC-157 have compelling evidence for gut mucosal healing, anti-inflammatory GI effects, and motility support. For patients with persistent gut inflammation or mucosal damage, BPC-157 is a valuable adjunct to a SIBO protocol.

When to Seek Care

If you have been diagnosed with IBS, experience chronic bloating that hasn't responded to standard treatment, or have documented nutritional deficiencies without an obvious cause, a SIBO evaluation is warranted. Book a consultation with our chronic disease team at RHPNY in NYC.

Medical Disclaimer: This article is for educational purposes only. SIBO diagnosis and treatment should be guided by a qualified physician with functional medicine training. Individual results and appropriate protocols vary.